Follow
Jan Pencik
Title
Cited by
Cited by
Year
JAK-STAT signaling in cancer: From cytokines to non-coding genome
J Pencik, HTT Pham, J Schmoellerl, T Javaheri, M Schlederer, Z Culig, ...
Cytokine 87, 26-36, 2016
2302016
STAT3 regulated ARF expression suppresses prostate cancer metastasis
J Pencik, M Schlederer, W Gruber, C Unger, SM Walker, A Chalaris, ...
Nature communications 6 (1), 7736, 2015
1772015
STAT5BN642H is a driver mutation for T cell neoplasia
HTT Pham, B Maurer, M Prchal-Murphy, R Grausenburger, ...
The Journal of clinical investigation 128 (1), 387-401, 2018
832018
STAT3‐dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer
M Oberhuber, M Pecoraro, M Rusz, G Oberhuber, M Wieselberg, ...
Molecular Systems Biology 16 (4), e9247, 2020
402020
IL-6/STAT3/ARF: the guardians of senescence, cancer progression and metastasis in prostate cancer
J Pencik, R Wiebringhaus, M Susani, Z Culig, L Kenner
Swiss Medical Weekly 145 (5152), w14215-w14215, 2015
332015
A rare castration‐resistant progenitor cell population is highly enriched in Pten‐null prostate tumours
L Sackmann Sala, F Boutillon, G Menara, A De Goyon‐Pélard, ...
The Journal of pathology 243 (1), 51-64, 2017
322017
A hydride transfer complex reprograms NAD metabolism and bypasses senescence
S Igelmann, F Lessard, O Uchenunu, J Bouchard, A Fernandez-Ruiz, ...
Molecular Cell 81 (18), 3848-3865. e19, 2021
292021
RETRACTED ARTICLE: Increased survival and cell cycle progression pathways are required for EWS/FLI1-induced malignant transformation
T Javaheri, Z Kazemi, J Pencik, HTT Pham, M Kauer, R Noorizadeh, ...
Cell death & disease 7 (10), e2419-e2419, 2016
252016
Thyroid and androgen receptor signaling are antagonized by μ‐crystallin in prostate cancer
O Aksoy, J Pencik, M Hartenbach, AA Moazzami, M Schlederer, T Balber, ...
International journal of cancer 148 (3), 731-747, 2021
172021
Breaking a paradigm: IL-6/STAT3 signaling suppresses metastatic prostate cancer upon ARF expression
Z Culig, J Pencik, O Merkel, L Kenner
Molecular & Cellular Oncology 3 (2), e1090048, 2016
92016
Proteomic analysis identifies NDUFS1 and ATP5O as novel markers for survival outcome in prostate cancer
R Wiebringhaus, M Pecoraro, HA Neubauer, K Trachtová, B Trimmel, ...
Cancers 13 (23), 6036, 2021
72021
STAT3/LKB1 controls metastatic prostate cancer by regulating mTORC1/CREB pathway
J Pencik, C Philippe, M Schlederer, E Atas, M Pecoraro, ...
Molecular Cancer 22 (1), 133, 2023
62023
STAT3-regulated ARF suppresses prostate cancer metastasis
J Pencik
Der Pathologe 37, 173-174, 2016
22016
Thyroid and androgen receptor signaling are antagonized by CRYM in prostate cancer
O Aksoy, J Pencik, M Hartenbach, AA Moazzami, M Schlederer, T Balber, ...
bioRxiv, 2019.12. 19.881151, 2019
12019
PO-217 Loss of Kmt2c methyltransferase activity contributes to prostate tumorigenesis in a mouse model of prostate cancer
T Limberger, M Schlederer, S Tangermann, J Pencik, M Hacker, ...
ESMO Open 3, A311-A312, 2018
12018
Building a 3D co-culture model for metastatic pancreatic ductal cancer using Curiochips microphysiological system
S Kim, Y Choi, J Baek, B Garg, J Pencik, AM Lowy, H Tiriac, S Yoo
Cancer Research 83 (7_Supplement), 1328-1328, 2023
2023
STAT3 restricts prostate cancer metastasis and antiandrogen resistance by controlling LKB1/CREB signaling pathway
J Pencik, C Philippe, M Schlederer, M Pecoraro, S Grund-Gröschke, WJ Li, ...
bioRxiv, 2022.08. 25.504915, 2022
2022
Cooperative Androgen and Thyroid Hormone Signaling Drives Prostate Cancer
O Aksoy, J Pencik, A Varady, A Moazzami, M Schlederer, T Balber, ...
EUROPEAN JOURNAL OF HUMAN GENETICS 27, 1595-1596, 2019
2019
STAT3-dependent systems-level analysis reveals PDK4 as an independent predictor of biochemical recurrence in prostate cancer
M Oberhuber, M Pecoraro, M Rusz, G Oberhuber, M Wieselberg, ...
bioRxiv, 770701, 2019
2019
μ-Crystalline as hormone antagonist in prostate cancer
O Merkel, O Aksoy, M Suzani, M Hassler, K Schlangen, T Balber, ...
Endocrine Abstracts 42, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20